This report aims to provide a comprehensive presentation of the global market for CMO and CDMO biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO and CDMO biotechnology. This report contains market size and forecasts of CMO and CDMO biotechnology in global, including the following market information:
Global CMO and CDMO biotechnology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CMO and CDMO biotechnology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Service Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CMO and CDMO biotechnology include Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CMO and CDMO biotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CMO and CDMO biotechnology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CMO and CDMO biotechnology Market Segment Percentages, by Type, 2022 (%)
Service
Product
Platform/ Expression System
Global CMO and CDMO biotechnology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CMO and CDMO biotechnology Market Segment Percentages, by Application, 2022 (%)
Large Enterprise
SME
Global CMO and CDMO biotechnology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CMO and CDMO biotechnology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CMO and CDMO biotechnology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CMO and CDMO biotechnology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Patheon
Catalent
Samsung Biologics
Lonza.
Boehringer Ingelheim
Samsung BioLogics
AGC Biologics
WuXi Biologics
AbbVie
Avid Bioservices
Fujifilm Diosynth Biotechnologies
KBI Biopharma (JSR Corporation)
Cytovance Biologics
Xpress Biologic
Rentschler Biopharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of CMO and CDMO biotechnology, market overview.
Chapter 2: Global CMO and CDMO biotechnology market size in revenue.
Chapter 3: Detailed analysis of CMO and CDMO biotechnology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CMO and CDMO biotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CMO and CDMO biotechnology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CMO and CDMO biotechnology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CMO and CDMO biotechnology Overall Market Size
2.1 Global CMO and CDMO biotechnology Market Size: 2022 VS 2032
2.2 Global CMO and CDMO biotechnology Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CMO and CDMO biotechnology Players in Global Market
3.2 Top Global CMO and CDMO biotechnology Companies Ranked by Revenue
3.3 Global CMO and CDMO biotechnology Revenue by Companies
3.4 Top 3 and Top 5 CMO and CDMO biotechnology Companies in Global Market, by Revenue in 2022
3.5 Global Companies CMO and CDMO biotechnology Product Type
3.6 Tier 1, Tier 2 and Tier 3 CMO and CDMO biotechnology Players in Global Market
3.6.1 List of Global Tier 1 CMO and CDMO biotechnology Companies
3.6.2 List of Global Tier 2 and Tier 3 CMO and CDMO biotechnology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CMO and CDMO biotechnology Market Size Markets, 2022 & 2032
4.1.2 Service
4.1.3 Product
4.1.4 Platform/ Expression System
4.2 By Type - Global CMO and CDMO biotechnology Revenue & Forecasts
4.2.1 By Type - Global CMO and CDMO biotechnology Revenue, 2018-2023
4.2.2 By Type - Global CMO and CDMO biotechnology Revenue, 2024-2032
4.2.3 By Type - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CMO and CDMO biotechnology Market Size, 2022 & 2032
5.1.2 Large Enterprise
5.1.3 SME
5.2 By Application - Global CMO and CDMO biotechnology Revenue & Forecasts
5.2.1 By Application - Global CMO and CDMO biotechnology Revenue, 2018-2023
5.2.2 By Application - Global CMO and CDMO biotechnology Revenue, 2024-2032
5.2.3 By Application - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global CMO and CDMO biotechnology Market Size, 2022 & 2032
6.2 By Region - Global CMO and CDMO biotechnology Revenue & Forecasts
6.2.1 By Region - Global CMO and CDMO biotechnology Revenue, 2018-2023
6.2.2 By Region - Global CMO and CDMO biotechnology Revenue, 2024-2032
6.2.3 By Region - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America CMO and CDMO biotechnology Revenue, 2018-2032
6.3.2 US CMO and CDMO biotechnology Market Size, 2018-2032
6.3.3 Canada CMO and CDMO biotechnology Market Size, 2018-2032
6.3.4 Mexico CMO and CDMO biotechnology Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe CMO and CDMO biotechnology Revenue, 2018-2032
6.4.2 Germany CMO and CDMO biotechnology Market Size, 2018-2032
6.4.3 France CMO and CDMO biotechnology Market Size, 2018-2032
6.4.4 U.K. CMO and CDMO biotechnology Market Size, 2018-2032
6.4.5 Italy CMO and CDMO biotechnology Market Size, 2018-2032
6.4.6 Russia CMO and CDMO biotechnology Market Size, 2018-2032
6.4.7 Nordic Countries CMO and CDMO biotechnology Market Size, 2018-2032
6.4.8 Benelux CMO and CDMO biotechnology Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia CMO and CDMO biotechnology Revenue, 2018-2032
6.5.2 China CMO and CDMO biotechnology Market Size, 2018-2032
6.5.3 Japan CMO and CDMO biotechnology Market Size, 2018-2032
6.5.4 South Korea CMO and CDMO biotechnology Market Size, 2018-2032
6.5.5 Southeast Asia CMO and CDMO biotechnology Market Size, 2018-2032
6.5.6 India CMO and CDMO biotechnology Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America CMO and CDMO biotechnology Revenue, 2018-2032
6.6.2 Brazil CMO and CDMO biotechnology Market Size, 2018-2032
6.6.3 Argentina CMO and CDMO biotechnology Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CMO and CDMO biotechnology Revenue, 2018-2032
6.7.2 Turkey CMO and CDMO biotechnology Market Size, 2018-2032
6.7.3 Israel CMO and CDMO biotechnology Market Size, 2018-2032
6.7.4 Saudi Arabia CMO and CDMO biotechnology Market Size, 2018-2032
6.7.5 UAE CMO and CDMO biotechnology Market Size, 2018-2032
7 CMO and CDMO biotechnology Companies Profiles
7.1 Patheon
7.1.1 Patheon Company Summary
7.1.2 Patheon Business Overview
7.1.3 Patheon CMO and CDMO biotechnology Major Product Offerings
7.1.4 Patheon CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.1.5 Patheon Key News & Latest Developments
7.2 Catalent
7.2.1 Catalent Company Summary
7.2.2 Catalent Business Overview
7.2.3 Catalent CMO and CDMO biotechnology Major Product Offerings
7.2.4 Catalent CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.2.5 Catalent Key News & Latest Developments
7.3 Samsung Biologics
7.3.1 Samsung Biologics Company Summary
7.3.2 Samsung Biologics Business Overview
7.3.3 Samsung Biologics CMO and CDMO biotechnology Major Product Offerings
7.3.4 Samsung Biologics CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.3.5 Samsung Biologics Key News & Latest Developments
7.4 Lonza.
7.4.1 Lonza. Company Summary
7.4.2 Lonza. Business Overview
7.4.3 Lonza. CMO and CDMO biotechnology Major Product Offerings
7.4.4 Lonza. CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.4.5 Lonza. Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Major Product Offerings
7.5.4 Boehringer Ingelheim CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Samsung BioLogics
7.6.1 Samsung BioLogics Company Summary
7.6.2 Samsung BioLogics Business Overview
7.6.3 Samsung BioLogics CMO and CDMO biotechnology Major Product Offerings
7.6.4 Samsung BioLogics CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.6.5 Samsung BioLogics Key News & Latest Developments
7.7 AGC Biologics
7.7.1 AGC Biologics Company Summary
7.7.2 AGC Biologics Business Overview
7.7.3 AGC Biologics CMO and CDMO biotechnology Major Product Offerings
7.7.4 AGC Biologics CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.7.5 AGC Biologics Key News & Latest Developments
7.8 WuXi Biologics
7.8.1 WuXi Biologics Company Summary
7.8.2 WuXi Biologics Business Overview
7.8.3 WuXi Biologics CMO and CDMO biotechnology Major Product Offerings
7.8.4 WuXi Biologics CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.8.5 WuXi Biologics Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie CMO and CDMO biotechnology Major Product Offerings
7.9.4 AbbVie CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Avid Bioservices
7.10.1 Avid Bioservices Company Summary
7.10.2 Avid Bioservices Business Overview
7.10.3 Avid Bioservices CMO and CDMO biotechnology Major Product Offerings
7.10.4 Avid Bioservices CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.10.5 Avid Bioservices Key News & Latest Developments
7.11 Fujifilm Diosynth Biotechnologies
7.11.1 Fujifilm Diosynth Biotechnologies Company Summary
7.11.2 Fujifilm Diosynth Biotechnologies Business Overview
7.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Major Product Offerings
7.11.4 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.11.5 Fujifilm Diosynth Biotechnologies Key News & Latest Developments
7.12 KBI Biopharma (JSR Corporation)
7.12.1 KBI Biopharma (JSR Corporation) Company Summary
7.12.2 KBI Biopharma (JSR Corporation) Business Overview
7.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Major Product Offerings
7.12.4 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.12.5 KBI Biopharma (JSR Corporation) Key News & Latest Developments
7.13 Cytovance Biologics
7.13.1 Cytovance Biologics Company Summary
7.13.2 Cytovance Biologics Business Overview
7.13.3 Cytovance Biologics CMO and CDMO biotechnology Major Product Offerings
7.13.4 Cytovance Biologics CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.13.5 Cytovance Biologics Key News & Latest Developments
7.14 Xpress Biologic
7.14.1 Xpress Biologic Company Summary
7.14.2 Xpress Biologic Business Overview
7.14.3 Xpress Biologic CMO and CDMO biotechnology Major Product Offerings
7.14.4 Xpress Biologic CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.14.5 Xpress Biologic Key News & Latest Developments
7.15 Rentschler Biopharma
7.15.1 Rentschler Biopharma Company Summary
7.15.2 Rentschler Biopharma Business Overview
7.15.3 Rentschler Biopharma CMO and CDMO biotechnology Major Product Offerings
7.15.4 Rentschler Biopharma CMO and CDMO biotechnology Revenue in Global Market (2018-2023)
7.15.5 Rentschler Biopharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CMO and CDMO biotechnology Market Opportunities & Trends in Global Market
Table 2. CMO and CDMO biotechnology Market Drivers in Global Market
Table 3. CMO and CDMO biotechnology Market Restraints in Global Market
Table 4. Key Players of CMO and CDMO biotechnology in Global Market
Table 5. Top CMO and CDMO biotechnology Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CMO and CDMO biotechnology Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CMO and CDMO biotechnology Revenue Share by Companies, 2018-2023
Table 8. Global Companies CMO and CDMO biotechnology Product Type
Table 9. List of Global Tier 1 CMO and CDMO biotechnology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CMO and CDMO biotechnology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CMO and CDMO biotechnology Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - CMO and CDMO biotechnology Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CMO and CDMO biotechnology Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global CMO and CDMO biotechnology Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - CMO and CDMO biotechnology Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CMO and CDMO biotechnology Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global CMO and CDMO biotechnology Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global CMO and CDMO biotechnology Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CMO and CDMO biotechnology Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CMO and CDMO biotechnology Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CMO and CDMO biotechnology Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CMO and CDMO biotechnology Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CMO and CDMO biotechnology Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CMO and CDMO biotechnology Revenue, (US$, Mn), 2024-2032
Table 30. Patheon Company Summary
Table 31. Patheon CMO and CDMO biotechnology Product Offerings
Table 32. Patheon CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 33. Patheon Key News & Latest Developments
Table 34. Catalent Company Summary
Table 35. Catalent CMO and CDMO biotechnology Product Offerings
Table 36. Catalent CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 37. Catalent Key News & Latest Developments
Table 38. Samsung Biologics Company Summary
Table 39. Samsung Biologics CMO and CDMO biotechnology Product Offerings
Table 40. Samsung Biologics CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 41. Samsung Biologics Key News & Latest Developments
Table 42. Lonza. Company Summary
Table 43. Lonza. CMO and CDMO biotechnology Product Offerings
Table 44. Lonza. CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 45. Lonza. Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim CMO and CDMO biotechnology Product Offerings
Table 48. Boehringer Ingelheim CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. Samsung BioLogics Company Summary
Table 51. Samsung BioLogics CMO and CDMO biotechnology Product Offerings
Table 52. Samsung BioLogics CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 53. Samsung BioLogics Key News & Latest Developments
Table 54. AGC Biologics Company Summary
Table 55. AGC Biologics CMO and CDMO biotechnology Product Offerings
Table 56. AGC Biologics CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 57. AGC Biologics Key News & Latest Developments
Table 58. WuXi Biologics Company Summary
Table 59. WuXi Biologics CMO and CDMO biotechnology Product Offerings
Table 60. WuXi Biologics CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 61. WuXi Biologics Key News & Latest Developments
Table 62. AbbVie Company Summary
Table 63. AbbVie CMO and CDMO biotechnology Product Offerings
Table 64. AbbVie CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 65. AbbVie Key News & Latest Developments
Table 66. Avid Bioservices Company Summary
Table 67. Avid Bioservices CMO and CDMO biotechnology Product Offerings
Table 68. Avid Bioservices CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 69. Avid Bioservices Key News & Latest Developments
Table 70. Fujifilm Diosynth Biotechnologies Company Summary
Table 71. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product Offerings
Table 72. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 73. Fujifilm Diosynth Biotechnologies Key News & Latest Developments
Table 74. KBI Biopharma (JSR Corporation) Company Summary
Table 75. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product Offerings
Table 76. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 77. KBI Biopharma (JSR Corporation) Key News & Latest Developments
Table 78. Cytovance Biologics Company Summary
Table 79. Cytovance Biologics CMO and CDMO biotechnology Product Offerings
Table 80. Cytovance Biologics CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 81. Cytovance Biologics Key News & Latest Developments
Table 82. Xpress Biologic Company Summary
Table 83. Xpress Biologic CMO and CDMO biotechnology Product Offerings
Table 84. Xpress Biologic CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 85. Xpress Biologic Key News & Latest Developments
Table 86. Rentschler Biopharma Company Summary
Table 87. Rentschler Biopharma CMO and CDMO biotechnology Product Offerings
Table 88. Rentschler Biopharma CMO and CDMO biotechnology Revenue (US$, Mn) & (2018-2023)
Table 89. Rentschler Biopharma Key News & Latest Developments
List of Figures
Figure 1. CMO and CDMO biotechnology Segment by Type in 2022
Figure 2. CMO and CDMO biotechnology Segment by Application in 2022
Figure 3. Global CMO and CDMO biotechnology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CMO and CDMO biotechnology Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global CMO and CDMO biotechnology Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CMO and CDMO biotechnology Revenue in 2022
Figure 8. By Type - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 9. By Application - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 10. By Type - Global CMO and CDMO biotechnology Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 12. By Application - Global CMO and CDMO biotechnology Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 14. By Region - Global CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 15. By Country - North America CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 16. US CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 17. Canada CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 20. Germany CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 21. France CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 23. Italy CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 24. Russia CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 28. China CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 29. Japan CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 32. India CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 34. Brazil CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa CMO and CDMO biotechnology Revenue Market Share, 2018-2032
Figure 37. Turkey CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 38. Israel CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 40. UAE CMO and CDMO biotechnology Revenue, (US$, Mn), 2018-2032
Figure 41. Patheon CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Catalent CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Samsung Biologics CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Lonza. CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boehringer Ingelheim CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Samsung BioLogics CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AGC Biologics CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. WuXi Biologics CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AbbVie CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Avid Bioservices CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cytovance Biologics CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Xpress Biologic CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Rentschler Biopharma CMO and CDMO biotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
